scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/S0966-842X(00)88986-6 |
P698 | PubMed publication ID | 8564359 |
P50 | author | Nathalie Winter | Q59018432 |
P2093 | author name string | J A Triccas | |
P W Roche | |||
P2860 | cites work | Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg | Q28269092 |
Tuberculosis: commentary on a reemergent killer | Q29614562 | ||
New use of BCG for recombinant vaccines | Q29615313 | ||
A strategy to improve the efficacy of vaccination against tuberculosis and leprosy | Q35604814 | ||
Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes | Q35782803 | ||
Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins | Q35782886 | ||
Tuberculosis and HIV infection in sub-Saharan Africa | Q35794493 | ||
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine | Q36361980 | ||
An immunogenetic view of delayed type hypersensitivity | Q36918362 | ||
Modern vaccines. Mycobacterial diseases | Q37584910 | ||
The present and future role of BCG vaccine in tuberculosis control | Q37943337 | ||
Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity | Q39004744 | ||
Gamma delta T lymphocytes in human tuberculosis | Q41637342 | ||
Bacillus Calmette-Guérin infection after vaccination of human immunodeficiency virus-infected children | Q43606175 | ||
Treatment of hepatic candidosis with liposomal amphotericin B in patient with acute leukaemia | Q43840557 | ||
Immunosuppression and alteration of resistance to pulmonary tuberculosis in guinea pigs by protein undernutrition | Q44064295 | ||
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature | Q57752071 | ||
Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines | Q59098577 | ||
What is BCG? | Q70446694 | ||
Influence of the virulence of Mycobacterium tuberculosis on protection induced by bacille Calmette-Guérin in guinea pigs | Q71553219 | ||
The BCG controversy. A methodological and statistical reappraisal | Q71691367 | ||
P433 | issue | 10 | |
P921 | main subject | tuberculosis | Q12204 |
BCG vaccine | Q798309 | ||
P304 | page(s) | 397-401 | |
P577 | publication date | 1995-10-01 | |
P1433 | published in | Trends in Microbiology | Q15265732 |
P1476 | title | BCG vaccination against tuberculosis: past disappointments and future hopes | |
P478 | volume | 3 |
Q46345591 | Animal models of tuberculosis |
Q35605940 | Approaches towards the development of a vaccine against tuberculosis: recombinant BCG and DNA vaccine |
Q83858682 | BCG vaccination of guinea pigs modulates Mycobacterium tuberculosis-induced CCL5 (RANTES) production in vitro and in vivo |
Q46287030 | BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components |
Q33756046 | Beyond BCG: the potential for a more effective TB vaccine |
Q40968692 | Characterization of the culture filtrate-specific cytotoxic T lymphocyte response induced by Bacillus Calmette-Guérin vaccination in H-2b mice |
Q30159872 | Computational identification of beta-barrel outer-membrane proteins in Mycobacterium tuberculosis predicted proteomes as putative vaccine candidates. |
Q34004438 | CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis |
Q57598814 | Cultivation of Mycobacterium bovis BCG in bioreactors |
Q36744717 | Current status of TB vaccines |
Q57598880 | Cytolytic T-cell responses to human dendritic cells and macrophages infected with Mycobacterium bovis BCG and recombinant BCG secreting listeriolysin |
Q57038792 | Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential |
Q33631222 | Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model. |
Q34053027 | Dose of incorporated immunodominant antigen in recombinant BCG impacts modestly on Th1 immune response and protective efficiency against Mycobacterium tuberculosis in mice. |
Q84293395 | Dry-powder pulmonary insufflation in the mouse for application to vaccine or drug studies |
Q35669625 | Drying a tuberculosis vaccine without freezing |
Q28487559 | Elements of signal transduction in Mycobacterium tuberculosis: in vitro phosphorylation and in vivo expression of the response regulator MtrA |
Q33755534 | Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis |
Q44070977 | Expression of interferon-gamma and tumour necrosis factor-alpha messenger RNA does not correlate with protection in guinea pigs challenged with virulent Mycobacterium tuberculosis by the respiratory route |
Q34000497 | Generation of CD8(+) T-cell responses to Mycobacterium bovis and mycobacterial antigen in experimental bovine tuberculosis |
Q61623133 | Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille calmette-Guérin (BCG) |
Q41720895 | Immunological relatedness of the protective mechanisms against tuberculosis and cancer |
Q37693346 | Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine |
Q40524651 | Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting |
Q35567441 | Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guérin-infected mice |
Q34009687 | Influence of Mycobacterium bovis bacillus Calmette Guérin on in vitro induction of CD1 molecules in human adherent mononuclear cells |
Q36044987 | Interleukin-15 as an Immune Adjuvant To Increase the Efficacy of Mycobacterium bovis Bacillus Calmette-Guérin Vaccination |
Q34280918 | Intracellular bacteria as targets and carriers for vaccination |
Q38031924 | Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology |
Q36793138 | Kinetics of IFN-gamma and TNF-alpha gene expression and their relationship with disease progression after infection with Mycobacterium tuberculosis in guinea pigs |
Q44559005 | Lung macrophages from bacille Calmette-Guérin-vaccinated guinea pigs suppress T cell proliferation but restrict intracellular growth of M. tuberculosis after recombinant guinea pig interferon-gamma activation |
Q34722855 | Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice |
Q36069312 | Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes |
Q47159990 | Mycobacterium tuberculosis components expressed during chronic infection of the lung contribute to long-term control of pulmonary tuberculosis in mice. |
Q39829844 | Production of tumor necrosis factor and nitric oxide by macrophages infected with live and dead mycobacteria and their suppression by an interleukin-10-secreting recombinant. |
Q53557432 | Protection of mice against Mycobacterium tuberculosis infection by immunization with aqueous fraction of Triton X-100-soluble cell wall proteins. |
Q54240070 | Protective efficacy of recombinant BCG over-expressing protective, stage-specific antigens of Mycobacterium tuberculosis. |
Q30332918 | Recent progress in the development and testing of vaccines against human tuberculosis. |
Q30387447 | Recombinant Mycobacterium bovis BCG as an HIV vaccine vector |
Q37251175 | The guinea pig as a model of infectious diseases. |
Q42663381 | The phosphatidyl-myo-inositol anchor of the lipoarabinomannans from Mycobacterium bovis bacillus Calmette Guérin. Heterogeneity, structure, and role in the regulation of cytokine secretion |
Q44273488 | Ultraviolet radiation reduces resistance to Mycobacterium tuberculosis infection in BCG-vaccinated guinea pigs |